MORPh Clinical Services

MORPh Clinical Services (MCS)

MORPh Clinical Services (MCS) brings together a wealth of experience in partnership working with the NHS and Pharma. MCS was created with the purpose of turning insight into action, harnessing the clinical expertise within our group to deliver outstanding patient outcomes.

MORPh is a pharmacist-led provider of1 Clinical Services and Training for Pharmacists and Pharmacy Technicians in the NHS, with over 11,000 current pharmacist members on our training network, we currently work with around 80% of the NHS across our group.

About our Service

Remote reviews are conducted in most cases – with dial in via DSPToolkit compliant software, working with all clinical systems
Team of in-house clinicians with all employment checks and indemnity assured
Patient data is not taken out of the system, our data sharing agreement is blessed by our existing NHS partners for use and we operate in a GDPR compliant manner

Supporting Lasting Improvements in Care

All of our clinical review services have a corresponding training package for GP teams, to provide a legacy of quality improvement. All programs are run with our team making recommendations that are in line with local formulary and guidelines, the purpose of the programs is to:

Improve patient outcomes
Support greater access to treatment and review
Educate GP teams
Promote cost-effective prescribing in line with local guidelines
Enhance the value of medicines to the patient and local healthcare economy

We have a number of therapy areas in which we can support General Practice and PCN objectives. Funding is provided in line with the ABPI code of conduct via the Pharma industry to support patient care, with options for grants to support programs in the following areas:

Diabetes reviews
Respiratory reviews in patients with asthma
Improving emollient prescribing
Optimising management of dry eye
Continence care – with nurse support to ensure that patients are supported in the community
Improving pain management with a focus upon transdermal pain relief step of the ladder
Review of prescribing in bone health
Optimising prescribing in Inflammatory bowel disease

We also have a diabetes program launching in June 2022, to support the intensification of patients across oral and injectable therapies with some nice innovative pieces to support pharmacists to take on more of a role within the diabetes care picture

News & Articles

Events

Clinical Services

Register